Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.
about
Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatomaOptimization of storage and stability of camel liver glutathione S-transferase.Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.Genomic and proteomic characterization of bacteriocin-producing Leuconostoc mesenteroides strains isolated from raw camel milk in two southwest Algerian arid zonesMolecular cloning, characterization and predicted structure of a putative copper-zinc SOD from the camel, Camelus dromedariusCamel milk triggers apoptotic signaling pathways in human hepatoma HepG2 and breast cancer MCF7 cell lines through transcriptional mechanism.Lactoferrin Isolation Using Monolithic Column Coupled with Spectrometric or Micro-Amperometric Detector.Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.Myrrh attenuates oxidative and inflammatory processes in acetic acid-induced ulcerative colitis.Influence of camel milk on the hepatitis C virus burden of infected patients.Survey of the camel urinary proteome by shotgun proteomics using a multiple database search strategy.Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions.Comparative Analysis of the Antiviral Activity of Camel, Bovine, and Human Lactoperoxidases Against Herpes Simplex Virus Type 1.Virucidal activity of human α- and β-defensins against hepatitis C virus genotype 4.The Therapeutic Effects of Camel Milk: A Systematic Review of Animal and Human Trials.Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and hela cell lines.Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C VirusExpression of recombinant Arabian camel lactoferricin-related peptide in Pichia pastoris and its antimicrobial identification.Why whey? Camel whey protein as a new dietary approach to the management of free radicals and for the treatment of different health disorders.Camelus dromedarius putative cytochrome P450 enzyme CYP2E1: complete coding sequence and phylogenetic tree.Camel milk beneficial effects on treating gentamicin induced alterations in rats.Through the eye of an electrospray needle: mass spectrometric identification of the major peptides and proteins in the milk of the one-humped camel (Camelus dromedarius).Medicinal values of bioactive constituents of camel milk: A concise report.Processing Challenges and Opportunities of Camel Dairy Products.Immunoenhancing property of dietary un-denatured whey protein derived from three camel breeds in micePotential antiviral activities of camel, bovine, and human lactoperoxidases against hepatitis C virus genotype 4Medicinal value of camel milk and meat
P2860
Q21245093-A8955B68-946B-42ED-A1FE-63CD96872FB5Q30364853-27B94F60-5D5D-47BD-981B-170247243EFDQ33863096-C806007C-4B18-4BEF-8CFE-E1D2B3D35569Q35165111-2A7FB6DD-FD69-4303-8AC3-DF5B9E8BB4D8Q35719509-132C3A57-89B0-440D-8E46-8818CBD8F154Q35986710-86EC4C08-F28B-48D8-8DB6-78C074C277B7Q36925109-F05F9AA9-EF0B-44FE-A169-033D59BC45D7Q36958593-D45F4685-CA15-4244-8542-55E31CFD3C70Q37107973-C7E4392D-2B7E-4E8B-A772-0C3BFDF12758Q37734598-D5ABCF3E-E9C7-48D2-97DE-9B4FB587BD59Q38494962-5CE49AE6-4AC9-4E77-8742-6A044A4C7FFFQ38504324-F48C3B71-9B2F-410D-8B39-D6CCD18D1468Q38730749-BD754C84-2B5F-44E6-9ACB-2316FDFB991DQ38763073-1943E88C-28FC-457C-8C23-A7896B5C5D1FQ38901920-AD170922-DFA7-47CC-9D08-5035635DA01CQ39701870-38E472D5-5D1A-484C-9DA8-DDE92459CF3DQ40407835-AC6096A0-58A4-4CBF-A234-F88B1E0E18C9Q41474238-DBC2A64B-5039-45B5-AE9B-F13A200FE5EDQ41877536-83457206-7035-4FC6-9030-685AAAC7D410Q42618514-5BA5D61E-1379-4B75-B95B-965F9A54E0ABQ42914648-D9F10DFF-9F0C-4E65-9522-5C26F519AAF1Q43482884-7223686A-8561-4E4D-A88A-5A19ABEA64E9Q44043769-C3380F6E-ECA9-4208-9C9D-28B228DF1CF5Q45957651-0C40BBF0-21C4-4109-A262-6ED03C5EBC40Q57804962-A09D4259-504F-4C3C-87D5-EC16AB9B6218Q58449674-1AC4A42D-FA96-4ACF-BB56-D11299F34313Q58851494-3714E97B-2C3D-4B22-90CA-A3BA0C986F75
P2860
Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Camel lactoferrin markedly inh ...... n peripheral blood leukocytes.
@en
Camel lactoferrin markedly inh ...... n peripheral blood leukocytes.
@nl
type
label
Camel lactoferrin markedly inh ...... n peripheral blood leukocytes.
@en
Camel lactoferrin markedly inh ...... n peripheral blood leukocytes.
@nl
prefLabel
Camel lactoferrin markedly inh ...... n peripheral blood leukocytes.
@en
Camel lactoferrin markedly inh ...... n peripheral blood leukocytes.
@nl
P50
P1476
Camel lactoferrin markedly inh ...... an peripheral blood leukocytes
@en
P2093
Ashraf Tabll
P304
P356
10.1080/15321810701454839
P577
2007-01-01T00:00:00Z